Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.
- DOI
- 10.1007/s00280-008-0903-7
- Published
- 2009 Aug
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-008-0903-7,
title = {Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.},
author = {Baize N and Abakar-Mahamat A and Mounier N and Berthier F and Caroli-Bosc FX},
year = {2009},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-008-0903-7},
url = {https://doi.org/10.1007/s00280-008-0903-7}
}RIS
TY - JOUR TI - Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens. AU - Baize N AU - Abakar-Mahamat A AU - Mounier N AU - Berthier F AU - Caroli-Bosc FX PY - 2009 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-008-0903-7 UR - https://doi.org/10.1007/s00280-008-0903-7 ER -
APA
N, B., A, A., N, M., F, B., & FX, C. (2009). Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-008-0903-7
Source records
- pubmed · retrieved 2026-09-25T19:07:46.053Z